Pyrazole compounds as nitrification inhibitors

US10556844B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10556844-B2
Application numberUS-201615548561-A
CountryUS
Kind codeB2
Filing dateFeb 5, 2016
Priority dateFeb 6, 2015
Publication dateFeb 11, 2020
Grant dateFeb 11, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Pyrazole derivatives as nitrification inhibitors are described herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for reducing nitrification, the method comprising: applying a composition comprising a compound of Formula I, or a stereoisomer, a salt, a tautomer, or N-oxide thereof, to a locus where nitrification occurs, wherein R 1 is C 4 -C 6 -alkynyl, propargyl, or C 3 -C 6 -allenyl, wherein the C-atoms of these groups optionally carry 1, 2, or 3 identical or different substituents selected from the group consisting of halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , O(C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , S(O) m R a , and S(O) m NR c R d ; R 2 , R 3 and R 4 are independently selected from the group consisting of H, halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , S(O) m R a , S(O) m NR c R d ; C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, wherein the C-atoms of these groups optionally carry 1, 2, or 3 identical or different substituents selected from the group consisting of halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , S(O) m R a , and S(O) m NR c R d ; C 6 -C 10 -aryl, and C 5 -C 10 -hetaryl, wherein the aromatic moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, OR a , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, and C 2 -C 4 -alkynyl; or R 3 and R 4 together form a bridge, which forms together with the atoms to which R 3 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic or heterocyclic ring, wherein the heterocyclic ring may carry 1, 2, or 3 heteroatoms being selected from O, S, and N, of which at least one of S and N may optionally be oxidized, and wherein the carbocyclic or heterocyclic ring optionally carries carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , O(C═O)NR c R d , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl, wherein the C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, C 1 -C 4 -alkyl, and C 1 -C 4 -haloalkyl; or R 2 and R 4 together form a bridge, which forms together with the atoms to which R 2 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic or heterocyclic ring, wherein the heterocyclic ring may carry 1, 2, or 3 heteroatoms being selected from O, S, and N, of which at least one of S and N may optionally be oxidized, and wherein the carbocyclic or heterocyclic ring optionally carries carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , O(C═O)NR c R d , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl, wherein the C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, C 1 -C 4 -alkyl, and C 1 -C 4 -haloalkyl; R a is selected from the group consisting of H, C 1 -C 8 -haloalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl; C 5 -C 10 -hetaryl and C 6 -C 10 -aryl, wherein the C 5 -C 10 -hetaryl or C 6 -C 10 -aryl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, OH, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 5 -C 6 -hetaryl and C 6 -aryl, wherein said C 5 -C 6 -hetaryl and C 6 -aryl moieties optionally carry 1, 2, 3, 4, or 5 substituents selected from the group consisting of halogen, CN, OH, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, and C 2 -C 4 -alkynyl; R b is selected from the group consisting of H, C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 4 -alkenyl, C 2 -C 8 -alkynyl, and C 6 -C 10 -aryl; R o and R d are independently selected from the group consisting of H, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 8 -cycloalkyl, C 6 -C 10 -aryl, and C 5 -C 10 -hetaryl; or R c and R d together with the N-atom to which they are bonded form a 5- to 6-membered, saturated or unsaturated heterocycle, which may carry a further heteroatom being selected from O, S, and N as a ring member atom, of which at least one S and N may optionally be oxidized, and wherein the heterocyclic ring optionally carries 1, 2, 3, 4, or 5 substituents, which are independently selected from the group consisting of halogen, CN, OH, NO 2 , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, and C 1 -C 4 -haloalkoxy; and m is 0, 1, or 2. 2. The method according to claim 1 , wherein: R 1 is a terminal C 4 -alkynyl group or propargyl. 3. The method according to claim 1 , wherein: R 1 is a terminal C 3 -C 4 -allenyl group. 4. The method according to claim 1 , wherein: R 2 , R 3 and R 4 are independently selected from the group consisting of H, halogen, CN, OR a , C(═O)R a , C(═O)OR a , C(═O)NR c R d ; C 1 -C 8 -alkyl, wherein the C-atoms optionally carry 1, 2, 3 identical or different substituents selected from the group consisting of halogen, CN, OR a ; C 6 -C 10 -aryl, and C 5 -C 10 -hetaryl, wherein the aromatic moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, OR a , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, and C 2 -C 4 -alkynyl; or R 3 and R 4 together form a bridge, which forms together with the atoms to which R 3 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic ring, wherein the carbocyclic ring optionally carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , O(C═O)NR c R d , C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl, wherein the C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, and C 1 -C 4 -haloalkyl; or R 2 and R 4 together form a bridge, which forms together with the atoms to which R 2 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic ring, wherein the carbocyclic ring optionally carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , O(C═O)NR c R d , C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl, wherein the C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, and C 1 -C 4 -haloalkyl; R a is selected from the group consisting of H, C 1 -C 8 -alkyl, C 1 -C 8 -haloalkyl, C 2 -C 8 -alkynyl; C 5 -C 10 -hetaryl or C 6 -C 10 -aryl, wherein the C 5 -C 10 -hetaryl or C 6 -C 10 -aryl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkynyl, C 5 -C 6 -hetaryl and C 6 -aryl, wherein said C 5 -C 6 -hetaryl and C 6 -aryl moieties optionally carry 1, 2, 3, 4, or 5 subs

Assignees

Inventors

Classifications

  • Benzopyrazoles; Hydrogenated benzopyrazoles · CPC title

  • C07D231/12Primary

    with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • A01N43/56Primary

    1,2-Diazoles; Hydrogenated 1,2-diazoles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10556844B2 cover?
Pyrazole derivatives as nitrification inhibitors are described herein.
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C07D231/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).